Minnema M, Nasserinejad K, Hazenberg B, et al. HOVON 104: results from a multicenter, prospective phase II study of bortezomib based induction treatment followed by autoogous stem cell transplantation in patients with de novo AL amyloidosis. EHA 2017, abstract S411.
Adviezen uit Amsterdam over VTE rondom de zwangerschap
okt 2020 | Benigne hematologie, Vasculaire geneeskunde